These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1973559)

  • 1. GYKI-12 743, a novel antihypertensive compound with special alpha-adrenergic blocking profile.
    Jaszlits L; Rabloczky G; Csókás G; Bódi I; Kürthy M; Horváth E; Kovács A; Jednákovits A; Arányi P; Mátyus P
    Acta Physiol Hung; 1990; 75 Suppl():155-6. PubMed ID: 1973559
    [No Abstract]   [Full Text] [Related]  

  • 2. Study of the predominant vascular postsynaptic alpha-adrenergic blocking capacity of GYKI-12 743 in isolated organs and pithed rats.
    Horváth E; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():145-6. PubMed ID: 1973558
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular and cardiac electrophysiological activity of GYKI-12 743 in isolated tissue preparations.
    Jednákovits A; Kovács A; Bódi I; Jaszlits L; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():157-8. PubMed ID: 1973560
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical effects of GYKI-12 743.
    Bakonyi A; Tömösközi Z; Heiczman A; Horváth EJ; Arányi P; Rabloczky G
    Acta Physiol Hung; 1990; 75 Suppl():19-20. PubMed ID: 2164749
    [No Abstract]   [Full Text] [Related]  

  • 5. [Alpha-adrenoblocking activity of a newly synthesized derivative of 1,4-benzodioxane].
    Staneva D; Spasov V; Ivanov D
    Eksp Med Morfol; 1984; 23(2):87-91. PubMed ID: 6147242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of rausedyl and pyrroxan on autoregulation of cerebral circulation].
    Gaevyĭ MD; Pogorelyĭ VE
    Biull Eksp Biol Med; 1983 Jul; 96(7):56-9. PubMed ID: 6135465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antagonism of bencianol (ZY 15051) and idazoxan (RX 781094) to norepinephrine in feline pial arteries in situ.
    Wahl M; Schilling L
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):205-15. PubMed ID: 2872863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo selectivity of prazosin but not of WB4101 for postsynaptic alpha-1 adrenoceptors.
    Massingham R; Dubocovich ML; Shepperson NB; Langer SZ
    J Pharmacol Exp Ther; 1981 May; 217(2):467-74. PubMed ID: 6112260
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (II).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):185-8. PubMed ID: 8688140
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychophysiologic aspect of regulating dyadic interpersonal interaction].
    Medvedev VI; Zav'ialova EK; Ovchinnikov BV; Posokhova ST
    Fiziol Cheloveka; 1986; 12(5):754-60. PubMed ID: 2880779
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and alpha,beta-adrenergic blocking potency of 2,3-dihydro-1,4-benzodioxin derivatives. (I).
    Khouili M; Guillaumet G; Coudert G; Pujol MD
    Farmaco; 1996 Mar; 51(3):175-84. PubMed ID: 8688139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic responses to WB4101 in anaesthetised and conscious rats.
    Mottram DR; Kapur H
    Gen Pharmacol; 1981; 12(6):471-5. PubMed ID: 6118316
    [No Abstract]   [Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of some WB4101 analogues bearing a naphthodioxanic nucleus.
    Castagnino E; Strappaghetti G; Corsano S; Gallucci P; Brasili L; Giardinà D
    Farmaco Sci; 1984 Jul; 39(7):569-74. PubMed ID: 6148262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity.
    Floch A; Advenier C
    J Pharmacol; 1985; 16(3):291-7. PubMed ID: 2866275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and hypotensive activity of some heterocyclic analogues of GYKI-12 743.
    Mátyus P; Kasztreiner E; Diesler E; Behr A; Varga I; Kosáry J; Rabloczky G; Jaszlits L
    Arch Pharm (Weinheim); 1994 Sep; 327(9):543-6. PubMed ID: 7979923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The alpha-adrenoceptor blocking effects of a new benzodioxane.
    Mottram DR; Kapur H
    J Pharm Pharmacol; 1975 Apr; 27(4):295-6. PubMed ID: 239130
    [No Abstract]   [Full Text] [Related]  

  • 17. [Lactogenic effect of pyrroxan, a Soviet alpha-adrenoblockader].
    Kolodina LN; Poskalenko AN; Korkhov VV; Barannikova TA
    Akush Ginekol (Mosk); 1976 Aug; (8):60-2. PubMed ID: 11702
    [No Abstract]   [Full Text] [Related]  

  • 18. Receptor interaction for the alpha-antagonist WB4101 (2(N[2,6-dimethyoxyphenoxyethyl])amino-methyl-1,4-benzodioxane).
    Kapur H; Mottram DR; Green PN
    J Pharm Pharmacol; 1978 Apr; 30(4):259-60. PubMed ID: 24721
    [No Abstract]   [Full Text] [Related]  

  • 19. Idazoxan and blood gas changes.
    Raptopoulos D; Koutinas A; Moustardas N; Papasteriadis A
    Vet Rec; 1988 Jan; 122(2):47. PubMed ID: 2896410
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacologic and therapeutic significance of alpha-adrenoceptor subtypes.
    Langer SZ; Duval N; Massingham R
    J Cardiovasc Pharmacol; 1985; 7 Suppl 8():S1-8. PubMed ID: 2417042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.